Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF‐κB‐Mediated Inflammation
Open Access
- 1 January 2018
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 9086747
Abstract
Andrographolide (Andro), a major bioactive component obtained from Andrographis paniculata Nees, has exerted wide antioxidant as well as cytoprotective properties. However, whether Andro treatment could retard the progress of diabetic cardiomyopathy (DCM) remains unknown. In this study, we evaluated the effects of Andro against diabetes‐induced myocardial dysfunction and explored the underlying mechanism in STZ‐induced diabetic mice. As a result, treatment with Andro dose dependently suppressed cardiac inflammation and oxidative stress, accompanied by decreasing cardiac apoptosis, which subsequently ameliorated cardiac fibrosis and cardiac hypertrophy. Further, Andro blocked hyperglycemia‐triggered reactive oxygen species (ROS) generation by suppressing NADPH oxidase (NOX) activation and augmenting nuclear factor erythroid 2‐related factor 2 (Nrf2) expression both in vitro and in vivo. Our results suggest that the cardioprotective effects afforded by Andro treatment involve the modulation of NOX/Nrf2‐mediated oxidative stress and NF‐κB‐mediated inflammation. The present study unravels the therapeutic potential of Andro in the treatment of DCM by attenuating oxidative stress, inflammation, and apoptosis.Keywords
Funding Information
- China Postdoctoral Science Foundation (2015M572055)
- Natural Science Foundation of Shandong Province (ZR201709250018, ZR2013HQ057)
- National Natural Science Foundation of China (81302939)
This publication has 41 references indexed in Scilit:
- Andrographolide suppresses high glucose-induced fibronectin expression in mesangial cells via inhibiting the AP-1 pathwayJournal of Cellular Biochemistry, 2013
- Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic RatsPLOS ONE, 2012
- Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failureProceedings of the National Academy of Sciences, 2012
- Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic CardiomyopathyDiabetes, 2012
- Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In VivoDiabetes, 2011
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic CardiomyopathyJACC, 2010
- Activation of Protein Kinase C Isoforms and Its Impact on Diabetic ComplicationsCirculation Research, 2010
- miR133a regulates cardiomyocyte hypertrophy in diabetesDiabetes/Metabolism Research and Reviews, 2009
- Human Apolipoprotein A-I Gene Transfer Reduces the Development of Experimental Diabetic CardiomyopathyCirculation, 2008
- HPLC determination of andrographolide in rat whole blood: study on the pharmacokinetics of andrographolide incorporated in liposomes and tabletsBiomedical Chromatography, 2007